.png?width=3840&quality=75&resize=contain)
CDMO
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility
Serán Bioscience
PR-09-24-NI-07Sep 17, 2024
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD, part of Thermo Fisher Scientific
PAO-08-24-CL-05Sep 16, 2024
Female-Centric
Transforming Drug Development through a Female Perspective
Chia Chia Sun; William Freimuth, Ph.D., M.D.
Fab Biopharma
PAO-09-24-CL-03Sep 10, 2024
Breakthrough Results
Breakthrough Results for Jardiance® (Empagliflozin) Confirm Emperor-preserved as First and Only Successful Trial for Heart Failure with Preserved Ejection Fraction
Eli Lilly and Company
PR-M07-21-04Sep 05, 2024
Comparability
Leveraging Risk Assessment for Demonstrating Product Comparability after Manufacturing Process Changes
Pawel Stanczak, Ph.D.; Xuemei Han, Ph.D.; Miguel Carrion
Tanvex CDMO
PAO-07-24-CL-08Aug 26, 2024
CDMO Model
Rethinking the Conventional CDMO Model
Wheeler Bio
PAO-08-24-CL-04Jul 29, 2024
Cell and Gene Therapy
Managing Complex Sample and IP Logistics in Support of Cell and Gene Therapies
Erin Schaller; Aidan Jones
PPD, part of Thermo Fisher Scientific
PAO-06-24-CL-11Jul 09, 2024
Synthetic DNA
Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA
Tom Merritt, Ph.D.
Touchlight
PAO-07-24-CL-01Jul 02, 2024
Digitalization
Overcoming Development Challenges with Digital Solutions
Wheeler Bio
PAO-06-24-CL-06Jul 02, 2024
Trusted Partnerships
Partnerships for Success
Ryan Lee
Samsung Biologics
PAO-06-24-CL-08Jun 25, 2024
Decentralized Clinical Trials
Implementation Challenges for Hybrid and Decentralized Clinical Trials
Hutan Ashrafian, M.D., Ph.D., MBA
YourBio Health
PAO-06-24-CL-03Jun 18, 2024
Clinical Trials
Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators
Dave Selkirk
Ergomed
PAO-06-24-CL-09May 30, 2024
Radioconjugate development
Expediting Radioimmune Conjugate Pharmaceuticals for First-In-Human Phase 0 Proof-of-Concept Human Studies from Stable Pool
Muctarr Sesay, Ph.D.; Natalia Bourguignon, Ph.D.
GBI
PAO-03-24-CL-07Mar 15, 2024
Clinical Trials Representation
Leveraging Decentralized Clinical Trial Strategies to Reduce Health Care Disparities
Jennifer Urwongse
PAO-03-24-CL-05Mar 13, 2024
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
NMDP
PR-M03-24-01Mar 05, 2024
Pediatric Clinical Trials
Pediatric Clinical Trials: Considerations for Enrollment and Retention
Susan McCune, M.D.; Anusha Streubel, M.D.; Elizabeth Donahue
PAO-02-24-CL-04Mar 01, 2024
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
Jo Varshney, Ph.D., D.V.M.
PAO-02-24-CL-10Feb 15, 2024
Robotic Sterile Fill-Finish
Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services
Peter Kim; Jerome Detreille; Derek Truninger
PAO-02-24-CL-03Feb 14, 2024
Decentralized Clinical Trials
An Adaptive Ecosystem of Solutions: Evolving Clinical Trials in a Decentralized World
Richie Pfeiffer
PPD, part of Thermo Fisher Scientific
PAO-12-23-CL-08Jan 17, 2024
Sustainable Clinical Trials
Fostering a Sustainable Future in Clinical Trials through Decentralized Trial Models
Michael J. Cohen
PPD, part of Thermo Fisher Scientific
PAO-12-23-CL-05Dec 13, 2023